Cytokine gene-modified vaccines in the therapy of cancer
Author:
- 1 January 1996
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 69 (1) , 1-14
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Interleukin-2 gene therapy of residual EL-4 leukaemia potentiates the effect of cyclophosphamide pretreatmentJournal of Cancer Research and Clinical Oncology, 1995
- In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectantJournal of Cancer Research and Clinical Oncology, 1994
- Recombinant Human Granulocyte Colony-Stimulating Factor in the Management of Cancer Patients: Five Years OnOncology, 1994
- Increasing tumour immunogenicity by genetic modificationEuropean Journal of Cancer, 1994
- Immunotherapy Via Gene TherapyJournal of Immunotherapy, 1993
- Anti‐metastatic vaccination of tumor‐bearing mice with il‐2‐gene‐inserted tumor cellsInternational Journal of Cancer, 1993
- Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinomaEuropean Journal of Cancer, 1992
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- There is more than one interleukin 1Immunology Today, 1986